Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir.

Sterling RK, Kuo A, Rustgi VK, Sulkowski MS, Stewart TG, Fenkel JM, El-Genaidi H, Mah'moud MA, Abraham GM, Stewart PW, Akushevich L, Nelson DR, Fried MW, Di Bisceglie AM

Open source

DOI
10.1111/apt.13095
Published
2015 Apr
Container
Alimentary pharmacology & therapeutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/apt.13095,
  title = {Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir.},
  author = {Sterling RK and Kuo A and Rustgi VK and Sulkowski MS and Stewart TG and Fenkel JM and El-Genaidi H and Mah'moud MA and Abraham GM and Stewart PW and Akushevich L and Nelson DR and Fried MW and Di Bisceglie AM},
  year = {2015},
  journal = {Alimentary pharmacology \& therapeutics},
  doi = {10.1111/apt.13095},
  url = {https://doi.org/10.1111/apt.13095}
}

RIS

TY  - JOUR
TI  - Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir.
AU  - Sterling RK
AU  - Kuo A
AU  - Rustgi VK
AU  - Sulkowski MS
AU  - Stewart TG
AU  - Fenkel JM
AU  - El-Genaidi H
AU  - Mah'moud MA
AU  - Abraham GM
AU  - Stewart PW
AU  - Akushevich L
AU  - Nelson DR
AU  - Fried MW
AU  - Di Bisceglie AM
PY  - 2015
JO  - Alimentary pharmacology & therapeutics
DO  - 10.1111/apt.13095
UR  - https://doi.org/10.1111/apt.13095
ER  - 

APA

RK, S., A, K., VK, R., MS, S., TG, S., JM, F., H, E., MA, M., GM, A., PW, S., L, A., DR, N., MW, F., & AM, D. B. (2015). Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir.. Alimentary pharmacology & therapeutics. https://doi.org/10.1111/apt.13095

Source records